Clinical Trial Update: Acute and Short-term Chronic Effects of Galvus (Vildagliptin) in Diabetes Type 2 Obese Women [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the acute and short-term effects of vildagliptin (Galvus) in obese women with type 2 diabetes, focusing on microvascular funct…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• Galvus (vildagliptin)

Snippet

Sponsor: Rio de Janeiro State University | Conditions: 1- Microvascular Function, 2-oxidative Stress | Phase 4 | Status: COMPLETED